Tag: ES-SCLC research advancements
Improved Survival in ES-SCLC with Lurbinectedin/Atezolizumab Combination
A combination of lurbinectedin and atezolizumab has shown significant benefits in overall survival (OS) and progression-free survival (PFS) for patients with extensive-stage small cell...